How to Use a Free Sales Certificate for Overseas Medical Device Registration?

Executive Summary

A Free Sales Certificate (FSC) is a document proving that a medical device is legally marketed in the exporting country. It facilitates registration or customs clearance in the importing country. Companies must first determine whether the target country recognizes FSCs and their role in the registration pathway. Typically, FSCs are used for low-risk product exemptions, expedited reviews, or as foundational registration documents. When preparing an FSC, companies must confirm product classification, existing registration certificates, quality management systems (ISO 13485 or MDSAP), technical documentation (including risk management and clinical evaluation), and labeling. Common risks include expired FSCs, product scope mismatches, and translation errors. Companies should establish an FSC management checklist: verify consistency between registered products and FSC models, confirm validity, prepare notarized translations, and clarify local agent responsibilities. Post-market changes affecting the FSC must be monitored, and timely renewals are essential. For multi-country registrations, core FSC documents can be reused, but packaging and labeling must be localized. AIMEILI recommends evaluating target country FSC requirements early in the project to avoid amendments; the manufacturer should retain control of the certificate and notify agents of changes.

Application Scenarios and Key Issues

Why Use a Free Sales Certificate?

Many countries require proof that a device is legally marketed in the exporting country for import registration. This proof is the Free Sales Certificate (FSC), typically issued by the exporting country's regulatory authority (e.g., NMPA). It serves as foundational evidence of the device's safety and effectiveness. The key question is: does an FSC equal a registration certificate? Not entirely. An FSC only confirms free sale in the exporting country, not completion of import registration. Companies must distinguish between two uses of the FSC: as supporting documentation for a registration application, or directly for customs clearance or market access exemption. For example, in GHWP member states (e.g., Saudi Arabia, ASEAN), low-risk devices can obtain registration directly with an FSC, while high-risk products still require full review. Additionally, some countries (e.g., Brazil, India) do not recognize foreign FSCs and require local registration or authorized representatives. Therefore, companies must verify target country regulations before using an FSC.

Registration Decision Logic

Step 1: Determine if the product falls under medical device regulation in the target country.

If the product has no clear classification or is non-medical in the exporting country, an FSC may not be issued or accepted. Step 2: Determine risk classification. The same product may have different classifications across countries, affecting FSC acceptance. For example, a Class II device in China may be considered Class I in the EU. Step 3: Select the registration pathway. Many countries offer accelerated pathways based on an FSC, provided the device is certified in the exporting country. Companies should evaluate whether existing NMPA, CE, FDA, or MDSAP certificates can support the FSC application. For instance, if a device holds CE (MDD/MDR) or FDA 510(k), the manufacturer can apply for an FSC from China's NMPA. However, note that the FSC only reflects the device's status in China; it does not apply if the country of origin is not China. Also, companies must verify who can apply: the manufacturer must be the certificate holder. If using contract manufacturing, contracts and authorizations are required. Additionally, consider if the target country requires GCP, GMP, or quality management system certificates (e.g., Indonesia requires ISO 13485 along with the FSC). For technical documentation, prepare instructions for use, labels, risk management reports, and clinical evaluations or evidence. For GHWP member states, core documents can be reused but must be translated into the local language. Post-market maintenance: FSCs are usually valid for one year and must be renewed; any product changes (design, process) require a new FSC; otherwise, import registration may be revoked.

Documents and Evidence

Required documents for FSC application: manufacturer's business license, medical device registration certificate, product technical requirements, instructions for use, labels, quality management system certificate (ISO 13485 or MDSAP), and the most recent inspection records. In some cases, a free sale declaration (issued by the manufacturer, notarized or certified by a chamber of commerce) is needed. Evidence chain: the FSC must be consistent with the import registration documents, including product name, model, specification, and classification. If the product is in the process of registration in a particular country, a "registration in progress" certificate may be used as a substitute, but it has limited validity. Important: the FSC must be an original or notarized copy, and translations must be certified. Common issues: if the product range includes multiple models, the FSC must list all models; if models differ significantly, it is advisable to apply for separate FSCs.

Common Mistakes

• Ignoring FSC expiration: Many companies fail to renew in time, leading to suspension of import registration. FSCs are typically valid for one year from issuance; renewal should start three months before expiry.
• Product scope mismatch: The product name or model on the FSC does not match the registration application in the target country. For example, a China registration certificate includes models A and B, but the FSC only lists A, rendering B unusable.
• Language translation errors: The target country requires a local language version that must match the original. Translation errors may be deemed fraudulent.
• Relying on agents to control the certificate: Some companies entrust the FSC to agents, losing control during changes or renewals. The certificate should be controlled by the manufacturer.
• Neglecting quality management system: An FSC often requires an attached ISO 13485 certificate. If the system certificate is expired or invalid, the FSC application will be rejected.
• Confusing country of origin: The FSC only proves market status in the issuing country. If a device is manufactured in China but holds a CE certificate, the Chinese FSC cannot be used for EU registration.

Company Preparation Checklist

• Confirm whether the target country accepts Chinese FSCs and specific requirements (e.g., notarization, translation, validity).
• Verify consistency between the exporting country registration certificate and the FSC, including product name, classification, model, and specification. Update the FSC promptly if the registration certificate changes.
• Prepare quality management system certificates (ISO 13485/MDSAP) and ensure they are valid.
• Organize technical documentation: instructions for use, labels, risk management reports, clinical evaluation documents, and translate into the target country's language.
• Appoint a local authorized representative (if required) and sign an agreement defining responsibilities, including receiving change notifications and renewal reminders.
• Establish an FSC management ledger: track validity, changes, and usage status. Set renewal alerts (90 days in advance).
• For multi-country registrations, prioritize unifying core product documents and using the FSC as a foundation to reduce duplicate efforts.

AIMEILI Expert View

Companies often mistakenly believe the FSC is a "master key," but several countries (e.g., the U.S., Japan) do not recognize Chinese FSCs and require local registration. Conduct regulatory research early in the project to determine the necessity of an FSC and alternatives. Reusable documents include product technical files, risk management reports, and clinical evaluations (if they meet international standards). Items that require localization: label and instruction translations, packaging design, and agent agreements. For multi-country registrations, complete the exporting country registration first, then apply for the FSC, and have the local agent submit the registration. The manufacturer must retain control of the certificate to avoid disruptions due to agent changes. Changes and renewals are common risks; consider engaging professional regulatory consultants for compliance management. Remember: the FSC is just the starting point; post-market surveillance (e.g., adverse event reporting, annual updates) is equally important.

Frequently Asked Questions

Can an expired FSC still be used?

No. After expiration, the importing country typically requires a new application or an extension certificate. Start the renewal process three months before expiry to avoid registration interruptions. Some countries may accept an expired FSC with an explanatory letter, but this is risky.

Can product models be omitted from the FSC?

No. The FSC must list all covered models; otherwise, omitted models cannot be used. If there are many models, apply for an FSC per series or issue separate certificates. Technical differences for each model must be reflected in the FSC.

Is a Chinese FSC valid across GHWP member states?

GHWP does not mandate mutual recognition of FSCs, but most member states accept Chinese FSCs as supporting documents, subject to specific conditions. For example, Saudi Arabia accepts FSCs for Class I devices, while Class II requires local testing. Some ASEAN countries also require an ISO 13485 certificate.

Implementation Recommendations

In practice, break down the task into five areas: regulatory assessment, document preparation, evidence reuse, localization, and post-market maintenance. This ensures early identification of gaps and aligns expectations across sales, R&D, quality, and regulatory teams regarding target country requirements. If entering multiple markets simultaneously, create a unified core technical file first, then supplement with country-specific authorizations, labels, language versions, forms, and local agent documentation. The efficiency of multi-country registration often depends on the uniformity of the initial document framework rather than the speed of individual submissions. Ensure each step is clear: confirm if the product falls under the target country's medical device scope, determine risk class and registration pathway, verify that technical documents, quality systems, and clinical evidence support each other, clarify local agent and authorized representative roles, and establish mechanisms for post-market changes, renewals, and vigilance.